Roche Ventana HER2 Dual ISH CDx
Roche launched the Ventana HER2 Dual ISH DNA Probe Cocktail assay for the detection of the HER2 biomarker in breast and gastric cancer.
HER2 is an important biomarker found in breast and gastric cancers, whose detection and inhibition can help to more effectively manage these aggressive cancers.
The Ventana HER2 Dual ISH DNA Probe Cocktail assay is designed to be completed within one day, enabling clinicians to get results back quicker than the most common methods of confirmatory testing for HER2, Roche said. Results can be read using light microscopy, eliminating the need for a specialized fluorescence microscope.